DV LOSS ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages DoubleVerify Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – DV
May 15, 2024 16:03 ET
|
The Rosen Law Firm PA
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of DoubleVerify...
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
May 15, 2024 16:01 ET
|
Journey Medical Corporation
SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses...
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 15, 2024 16:01 ET
|
Mereo BioPharma Group plc
LONDON, May 15, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its...
Navios Maritime Holdings Inc. Provides Important Reminder for All Holders of Series G and Series H American Depositary Shares: Early Tender Deadline to Receive $5.75 in Cash Is May 21, 2024, 5:00 P.M.
May 15, 2024 16:01 ET
|
Navios Maritime Holdings, Inc.
GRAND CAYMAN, Cayman Islands, May 15, 2024 (GLOBE NEWSWIRE) -- Navios Maritime Holdings Inc. (“Navios Holdings” or the “Company”), today provided a reminder of its previously announced tender offer...
Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and Clobetasol
May 15, 2024 16:01 ET
|
Eyenovia, Inc.
Remains on track towards accelerating development of its late-stage product candidate in the multi-billion-dollar pediatric progressive myopia market, MicroPine Preparing for a 3Q 2024 launch of the...
Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
May 15, 2024 16:01 ET
|
Celcuity Inc.
The Phase 3 VIKTORIA-1 trial remains on track to report topline data from PIK3CA wild type patient sub-group in the second half of 2024First patient dosed in a Phase 1b/2 clinical trial evaluating...
CSX Executive Vice President and Chief Financial Officer to Address Wolfe Research Global Transportation & Industrials Conference
May 15, 2024 16:01 ET
|
CSX Corporation
JACKSONVILLE, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) Executive Vice President and Chief Financial Officer, Sean Pelkey, will address the 17th Annual Wolfe Research Global...
Xometry Appoints Subir Dutt As Chief Sales Officer
May 15, 2024 16:01 ET
|
Xometry, Inc.
Xometry Appoints Subir Dutt As Chief Sales Officer
Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules
May 15, 2024 16:01 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC)...
Five Below, Inc. Announces First Quarter Fiscal 2024 Earnings Release and Conference Call Date
May 15, 2024 16:01 ET
|
Five Below, Inc.
PHILADELPHIA, PA, May 15, 2024 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE), the trend-right, high-quality, extreme-value retailer for tweens, teens and beyond, today announced that its...